# Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation

> **NCT02139696** · — · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 10 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **RADIATION:** PET and MRI

## Key facts

- **NCT ID:** NCT02139696
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-01
- **Final completion:** 2016-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02139696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02139696, "Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02139696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*